RESUMO
Background Saudi Vision 2030 is transforming the country's healthcare system, with efficacy, accessibility, and patient satisfaction with healthcare services serving as key indicators for assessing patient care quality. As blindness and impaired vision continue to be a rising health issue in most Eastern Mediterranean Region (EMR) nations, including Saudi Arabia, this study focused on measuring patient satisfaction with healthcare services in ophthalmology clinics. Objectives This study aimed to assess the level of patient satisfaction with healthcare services in ophthalmology clinics and its related factors in the Makkah region of Saudi Arabia in 2022-2023. Methods A cross-sectional study was conducted on a convenience sample of 553 Saudi and non-Saudi patients, aged 18 years and older, who attended private and government ophthalmology clinics in the Makkah region of Saudi Arabia during the period between November 2022 and February 2023. A self-administered questionnaire was distributed on several electronic platforms like WhatsApp, X (formerly known as Twitter), Telegram, and Snapchat to collect the data. Finally, all the data were entered and analyzed through the IBM SPSS software version 26. Results A total of 553 responses were obtained. The majority were aged between 18 and 35 years old (76.5%, n=423), with the female gender being dominant (79.7%, n=441). More than half of them (52.3%, n=289) preferred to receive ophthalmological healthcare services from governmental hospitals. The most commonly diagnosed eye disease was refractive error (43.2%, n=239). Patient satisfaction with healthcare services provided in ophthalmology clinics represented 75% (n=415). The odds of being satisfied with ophthalmology clinics are expected to decrease by at least 44% among individuals over the age of 35 (odds ratio (OR) =0.437; 95% CI=0.257-0.743; p=0.002). Moreover, those who had been married were predicted to decrease the chance of being satisfied by at least 50% compared to patients who had never been married (OR=0.538; 95% CI=0.352-0.823; p=0.004). Compared to students, patients who were currently employed were predicted to decrease the chance of being satisfied by at least 48% (OR = 0.481; 95% CI=0.270-0.856; p=0.013). Additionally, those with a higher monthly income had decreased odds of being satisfied by at least 58% (OR=0.583; 95% CI=0.381-0.893; p=0.013). In contrast, compared to patients with associated comorbidity, patients who have no comorbidity were predicted to have an increased chance of being satisfied by at least two-fold than those who had comorbidities (OR=2.023; 95% CI=1.199-3.413; p=0.008). Conclusions The study concludes that 75% of the patients attending ophthalmology clinics in the Makkah region of Saudi Arabia were satisfied with the healthcare services provided in these clinics. Most patients acknowledged the time of care, doctors' professionalism, continuity of care, comprehensive examination, and their education about their disease and management, in addition to doctors listening to them during their visits to ophthalmology clinics. Factors affecting patient satisfaction with medical services in ophthalmology clinics are patient age, occupation, marital status, monthly income, and associated comorbidities. Further studies are recommended to deeply understand patients' needs and obtain more suggestions to be fully satisfied with healthcare services in ophthalmology clinics and other different healthcare facilities.
RESUMO
Background: Soon after the COVID-19 pandemic was declared, a pharmaceutical company expressed rapid interest in developing a safe and effective vaccine candidate to contain the spread of SARS-CoV-2 infections. The FDA approved the Pfizer-BioNTech, AstraZeneca, Moderna, and Janssen vaccines. Here, we investigated the attitude and acceptance of using different generic types of COVID-19 vaccines in Saudi Arabia. Methods: This study is a cross-sectional study using an online survey conducted in Saudi Arabia from the 19th of October to the 6th of December 2021. The questionnaire was distributed using social media platforms such as Twitter, WhatsApp, and Facebook. The inclusion criteria to participate in this study were adults who live in Saudi Arabia (Saudis or non-Saudis) and had two doses of COVID-19 vaccinations. Result: 3486 participants were included in this study, and 67.5% of the participants had side effects after the first dose. Similarly, 66.7% of the study participants had side effects after administering the second dose. Our data showed that most participants were unsure if the heterologous COVID-19 vaccination could cause severe side effects. In addition, 47.6% of the participants refused to receive a different generic type of COVID-19 vaccine due to fear of health problems. However, most participants obtained information regarding COVID-19 vaccination from the Saudi Ministry of Health. Conclusions: We found a low level of acceptance for receiving different generic types of vaccines if the participants had a choice. Therefore, plans should focus on increasing the acceptance level among the Saudi population through official platforms such as the Saudi Ministry of Health and private clinics.
